A study of nearly 280,000 women in the United States has found that living in areas with a high level of fine particles from air pollution may increase a woman’s chance of having dense breasts – a well-established risk factor for breast cancer – according to a new study published in the open access journal Breast Cancer Research.
The study, the largest of its kind to investigate the association of air pollution with breast density, found that for every one unit increase in fine particle concentration (PM2.5), a woman’s chance of having dense breasts was increased by 4%. Women with dense breasts were around 20% more likely to have been exposed to higher concentrations of PM2.5. Conversely, women with less dense, or breasts with more fatty tissue, were 12% less likely to have been exposed to high concentrations of PM2.5.
Breast density is measured by mammography and reflects the relative amounts of different tissue types in the breast. Breasts with a majority of fatty tissue are easier to interpret by mammography and so abnormalities become easier to spot. Dense breasts contain a higher percentage of fibroglandular tissue which obscures mammography and makes it difficult to identity abnormalities such as a breast tumour.
Dr Lusine Yaghjyan, lead author from the University of Florida, said: “Our findings suggest that previously reported geographic variation in breast density could, in part, be explained by different air pollution patterns in urban and rural areas. Breast density is a well-established and strong breast cancer risk factor so future studies are warranted to determine if the observed associations are causal, which if confirmed may have implications for risk prevention.”
The researchers also looked at the association between ozone exposure and breast density among the 280,000 women included in the study. They found that every one unit increase in ozone concentration was associated with a 3% lower chance of having dense breasts.
Dr Yaghjyan explained: “We found a positive association between fine particle concentration exposure and breast density but an inverse association between ozone exposure and breast density. This is an intriguing result that warrants further investigation to unpick any possible biological mechanism that might cause ozone exposure to reduce a woman’s chance of having dense breasts.”
Chemical constituents of PM2.5 air pollution are known to include pollutants that have endocrine disrupting properties. According to the researchers, although causation cannot be established in this observational study, due to uncontrolled factors, these pollutants could potentially influence breast density by interfering with growth of cells in the breast and increasing the relative amount of fibroglandular tissue.
Women for this study were selected from the Breast Cancer Surveillance Consortium, a population-based cohort of women undergoing mammographic screening across the United States. Mammographic data, including breast density, was included from women who were screened between 2001 and 2009. Breast density was measured using the BI-RADS system, a method developed by the American College of Radiology to standardise beast density measurements. Air pollution data corresponding to the areas where the women lived before or around the time of their mammogram was obtained from the United States Environment Protection Agency.
T: +44 (0)20 3192 2722
M: +44 (0)75 4079 9187
1. Research article:
Association of air pollution with mammographic breast density in the Breast Cancer Surveillance Consortium
Yaghjan et al.
Breast Cancer Research April 2017
After the embargo lifts, the article will be available at the journal website here: https://0-breast--cancer--research-biomedcentral-com.brum.beds.ac.uk/articles/10.1186/s13058-017-0828-3
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Nature, a major new force in scientific, scholarly, professional and educational publishing, created in May 2015 through the combination of Nature Publishing Group, Palgrave Macmillan, Macmillan Education and Springer Science+Business Media. www.biomedcentral.com